Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Ilaris approved in U.S. for active Still's disease

June 17, 2020

Netakimab demonstrates superiority to placebo in second-line psoriatic arthritis

June 17, 2020

Domain Therapeutics' biased PAR2 inhibitors show antiarthritic effects

June 11, 2020

AbbVie reports new phase IIa data on ABBV-3373 in moderate to severe rheumatoid arthritis

June 11, 2020

Modified peptides generate RA-specific CD4+ T cells with lytic properties against APCs

June 11, 2020

Dual JAK1/TYK2 inhibitor TLL-018 shows dose-dependent anti-inflammatory activity in arthritis models

June 10, 2020

Momelotinib shows efficacy in RA and RA-induced anemia in preclinical rodent models

June 9, 2020

FDA clears IND application for BX-U001 in rheumatoid arthritis

June 8, 2020

Kezar reports updated phase Ib findings on KZR-616 in SLE

June 4, 2020

MAP3K5 inhibitors discovered at Enanta Pharmaceuticals

June 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...